Skip to main content

Peer Review reports

From: Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial

Original Submission
22 Nov 2016 Submitted Original manuscript
10 Mar 2017 Author responded Author comments - Luca Filippi
Resubmission - Version 2
10 Mar 2017 Submitted Manuscript version 2
29 Mar 2017 Reviewed Reviewer Report - Brian William Fleck
20 Apr 2017 Reviewed Reviewer Report - Yannis Paulus
16 May 2017 Author responded Author comments - Luca Filippi
Resubmission - Version 3
16 May 2017 Submitted Manuscript version 3
17 May 2017 Reviewed Reviewer Report - Brian William Fleck
8 Jun 2017 Reviewed Reviewer Report - Yannis Paulus
28 Jun 2017 Author responded Author comments - Luca Filippi
Resubmission - Version 4
28 Jun 2017 Submitted Manuscript version 4
Publishing
5 Jul 2017 Editorially accepted
14 Jul 2017 Article published 10.1186/s12887-017-0923-8

You can find further information about peer review here.

Back to article page